Drug Database
Back to search

Switzerland· 67431004

Triogen 250 mg, Kapseln

A trientine product containing trientini dihydrochloridum, registered in Switzerland by IDEOGEN AG and dispensed under Swissmedic category B. The same ATC class is registered in 19 of our 19 countries.

Cat B (Swissmedic)ATC A16AX12

Checked against Swissmedic (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHSwissmedic (Switzerland)normalisedTriogen 250 mg, KapselnATCA16AX12REGISTER NO.67431004PACKS LISTED0CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about trientini dihydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Trientine is registered in 19 of 19 countries.

Countries holding a registration under ATC A16AX12 (trientine), each read from that country’s own register.

  • This record: Switzerland, from Swissmedic (Switzerland)
  • 11 of them publish a price we can compare per daily dose
Search trientine products by name

Trientine · ATC A16AX12

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of trientine costs, country by country.

Normalised to the WHO defined daily dose (0.45 g), the median price runs from $97.54 in Switzerland to $186.45 in Italy — a ×1.9 gap.

  • Switzerland: $97.54 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Trientine · price per daily dose (0.45 g)

USD · FX 28 Sept 2026

  • IT Italy$186.45
  • CH Switzerland$97.54
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Swissmedic (Switzerland)
Active substance
trientini dihydrochloridum
Manufacturer
IDEOGEN AG
Country
Switzerland (CH)
ATC code
A16AX12
ATC class
Trientine
Defined daily dose
0.45 g, O
Swissmedic category
B
Reimbursed
No
Source register
Swissmedic (Switzerland)
Last checked
September 12, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

35 interactions on record for trientine.

Graded by severity as the source publishes them — 31 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check trientine against other medicinesHow interaction checks work

Trientine · interactions on record

35 records

  • 31 moderate
  • 4 minor

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Trientine in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trientine products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Aveleris, Trientin
  • Belgium · Aveleris
  • Czechia · Trientine Tillomed
  • Germany · Aveleris, Trientin Waymade
  • Denmark · Trientin Waymade, Trientine Tillomed
  • Spain · Trientina
  • Finland · Trientine Tillomed, Trientine Waymade
  • France · Trientine Tillomed, Trientine Waymade
  • United Kingdom (Northern Ireland) · Trientine, Trientine Dihydrochloride Tillomed
  • Greece · Trientine Tillomed, Trientine Waymade
  • Ireland · Trientine Tillomed, Trientine Tillomed Pharma
  • Iceland · Cufence, Cuprior
  • Italy · Trientina Ideogen, Trientina Waymade
  • Liechtenstein · Cufence, Cuprior
  • Luxembourg · Aveleris
  • Netherlands · Aveleris, Trientine Waymade
  • Norway · Cufence, Cuprior
  • Portugal · Trientina Tillomed, Trientina Waymade
  • Sweden · Trientine Tillomed, Trientine Waymade
  • Slovakia · Trientine Tillomed

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swissmedic (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d903a1ae-a2ee-4c76-a633-7ce212d62ea2
GET /v1/drugs/d903a1ae-a2ee-4c76-a633-7ce212d62ea2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{}
API referenceMCP serverPlans

See everything about trientine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console